In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Singulex, Inc.

https://www.singulex.com/

Latest From Singulex, Inc.

Inivata Names Clive Morris New CEO

Inivata's Chief Medical Officer Clive Morris will take over as CEO of the liquid biopsy company. Former CEO Michael Stocum departed earlier this year.

Appointments Companies

Singulex And Qiagen Partner In Personalized Medicine

Singulex and Qiagen have entered a strategic alliance whereby Qiagen will be able to offer its clients companion diagnostic development services based on Singulex’s Single Molecule Counting technology.

Deals In Vitro Diagnostics

Singulex’ Cardiac Troponin Test Predicts Cardiac Risk In Stable Patients

Results of from a new analysis of plasma samples from an old statin trial suggest that Singulex’ high-sensitivity cardiac troponin test can track the cardiovascular risk in stable patients with ischemic heart disease.

Cardiology In Vitro Diagnostics

Singulex: Next-Gen Immunodiagnostics

Singulex originally developed its Single Molecule Counting technology for research applications, but it is poised to launch a clinical diagnostics tool that incorporates the highly sensitive technology.

Innovation Medical Device
See All

Company Information

  • Industry
  • Digital Health
  • Services
  • Services
    • Diagnostic Imaging Services
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
UsernamePublicRestriction

Register